Bioanalytical readings return to normal following MSC administration, emphasizing the potential in managing COVID-19-induced complications. MSC therapy offers a potential
StemCyte announced today that its Hematopoietic Progenitor Cell Cord Blood therapy (HPC Cord Blood) has officially obtained the Regenerative Medicine
MSC-treated group showed significantly lower risk of mortality than the control group (p = 0.03). No statistical significance was observed
New research from Boston Medical Center and Boston University Chobanian & Avedisian School of Medicine’s Center for Regenerative Medicine (CReM)
“The cells we transplant are early-stage neurons that are in the process of developing into dopamine cells, but that have
In the past year, 136 patients received treatment, leading to a total of 473 stem cell administrations. Patients who underwent
Starting from the late 1980s, stem cell scientists attempted CRT using fVM tissues dissected from aborted embryos (typically 6 to
Huge advances in technology make it possible to turn precursor cells, derived from pluripotent stem cells, into dopamine-producing neurons. We
People have been waiting a long time for a cure for Type 1 diabetes. Hannah Pizzato, PhD, is one of
Exciting developments reported in China with regenerative methods to treat diabetes
The RHA.org Your Trusted Guide to Regenerative Health
© 2024 All Rights Reserved.